BAVENCIO™

Merck Outlines Resilience and Growth Strategy, Targets Fiscal 2024 for Sales Uptick

(IN BRIEF) Merck, a leading science and technology company, has announced its expectation to return to organic sales growth in…

7 months ago

Merck to Showcase Oncology Portfolio Advancements at ESMO 2023, Highlighting Key Cancer Treatment Breakthroughs

(IN BRIEF) Merck, a leading science and technology company, is set to present 28 abstracts at the 2023 European Society…

7 months ago

Merck: EMD Serono, Pfizer Canada receive approval for BAVENCIO™ from Health Canada

First Health Canada approved treatment for rare and aggressive type of skin cancer MISSISSAUGA, ON, 26-Feb-2018 — /EuropaWire/ — Merck, which…

6 years ago